Supramolecular chemotherapy based on host–guest molecular recognition: a novel strategy in the battle against cancer with a bright future DOI
Jiong Zhou, Guocan Yu, Feihe Huang

et al.

Chemical Society Reviews, Journal Year: 2017, Volume and Issue: 46(22), P. 7021 - 7053

Published: Jan. 1, 2017

Chemotherapy is currently one of the most effective ways to treat cancer. However, traditional chemotherapy faces several obstacles clinical trials, such as poor solubility/stability, non-targeting capability and uncontrollable release drugs, greatly limiting their anticancer efficacy causing severe side effects towards normal tissues. Supramolecular integrating non-covalent interactions a highly promising candidate in this regard can be appropriately used for targeted drug delivery. By taking advantage supramolecular chemistry, some limitations impeding applications solved effectively. Therefore, we present here review summarizing progress cancer treatment based on host-guest recognition provide guidance design new targeting combining diagnostic therapeutic functions. Based large number state-of-the-art studies, our will advance basis promote translational applications.

Language: Английский

Principles of nanoparticle design for overcoming biological barriers to drug delivery DOI
Elvin Blanco, Haifa Shen,

Mauro Ferrari

et al.

Nature Biotechnology, Journal Year: 2015, Volume and Issue: 33(9), P. 941 - 951

Published: Sept. 1, 2015

Language: Английский

Citations

5723

Cancer nanomedicine: progress, challenges and opportunities DOI Open Access
Jinjun Shi, Philip W. Kantoff,

Richard Wooster

et al.

Nature reviews. Cancer, Journal Year: 2016, Volume and Issue: 17(1), P. 20 - 37

Published: Nov. 11, 2016

Language: Английский

Citations

4934

Clinical development and potential of photothermal and photodynamic therapies for cancer DOI
Xingshu Li, Jonathan F. Lovell, Juyoung Yoon

et al.

Nature Reviews Clinical Oncology, Journal Year: 2020, Volume and Issue: 17(11), P. 657 - 674

Published: July 22, 2020

Language: Английский

Citations

2548

Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer DOI
Yijing Liu, Pravin Bhattarai,

Zhifei Dai

et al.

Chemical Society Reviews, Journal Year: 2018, Volume and Issue: 48(7), P. 2053 - 2108

Published: Sept. 27, 2018

The nonradiative conversion of light energy into heat (photothermal therapy, PTT) or sound (photoacoustic imaging, PAI) has been intensively investigated for the treatment and diagnosis cancer, respectively. By taking advantage nanocarriers, both imaging therapeutic functions together with enhanced tumour accumulation have thoroughly studied to improve pre-clinical efficiency PAI PTT. In this review, we first summarize development inorganic organic nano photothermal transduction agents (PTAs) strategies improving PTT outcomes, including applying appropriate laser dosage, guiding via techniques, developing PTAs absorption in second NIR window, increasing (PCE), also tumours. Second, introduce advantages combining other therapies cancer treatment. Third, emerging applications cancer-related research are exemplified. Finally, perspectives challenges combating especially regarding their clinical translation, discussed. We believe that having noteworthy features would become promising next-generation non-invasive theranostic techniques our ability combat cancers.

Language: Английский

Citations

2459

Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release DOI
Nazila Kamaly, Basit Yameen, Jun Wu

et al.

Chemical Reviews, Journal Year: 2016, Volume and Issue: 116(4), P. 2602 - 2663

Published: Feb. 8, 2016

ADVERTISEMENT RETURN TO ISSUEPREVReviewNEXTDegradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug ReleaseNazila Kamaly§, Basit Yameen§, Jun Wu§, Omid C. Farokhzad*§‡View Author Information§ Laboratory Nanomedicine Biomaterials, Department Anesthesiology, Brigham Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, United States‡ King Abdulaziz University, Jeddah 21589, Saudi Arabia*E-mail: [email protected]Cite this: Chem. Rev. 2016, 116, 4, 2602–2663Publication Date (Web):February 8, 2016Publication History Received8 June 2015Published online8 February 2016Published inissue 24 2016https://pubs.acs.org/doi/10.1021/acs.chemrev.5b00346https://doi.org/10.1021/acs.chemrev.5b00346review-articleACS PublicationsCopyright © 2016 American Chemical SocietyRequest reuse permissionsArticle Views40762Altmetric-Citations1996LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum full text article downloads since November 2008 (both PDF HTML) across all institutions individuals. These metrics regularly updated to reflect usage leading up last few days.Citations number other articles citing this article, calculated by Crossref daily. Find more information about citation counts.The Altmetric Attention Score is a quantitative measure attention that research has received online. Clicking on donut icon will load page at altmetric.com with additional details score social media presence for given article. how calculated. Share Add toView InAdd Full Text ReferenceAdd Description ExportRISCitationCitation abstractCitation referencesMore Options onFacebookTwitterWechatLinked InRedditEmail Other access optionsGet e-Alertsclose SUBJECTS:Copolymers,Drug delivery,Drug release,Pharmaceuticals,Polymers Get e-Alerts

Language: Английский

Citations

2428

Delivery technologies for cancer immunotherapy DOI
Rachel Riley, Carl H. June, Róbert Langer

et al.

Nature Reviews Drug Discovery, Journal Year: 2019, Volume and Issue: 18(3), P. 175 - 196

Published: Jan. 8, 2019

Language: Английский

Citations

2129

Progress and challenges towards targeted delivery of cancer therapeutics DOI Creative Commons
Daniel Rosenblum, Nitin Joshi, Wei Tao

et al.

Nature Communications, Journal Year: 2018, Volume and Issue: 9(1)

Published: April 11, 2018

Targeted delivery approaches for cancer therapeutics have shown a steep rise over the past few decades. However, compared to plethora of successful pre-clinical studies, only 15 passively targeted nanocarriers (NCs) been approved clinical use and none actively NCs advanced trials. Herein, we review principles behind determine potential reasons their limited translation success. We propose criteria considerations that must be taken into account development novel NCs. also highlight possible directions tumor targeting strategies.

Language: Английский

Citations

1824

Nanotechnology for Multimodal Synergistic Cancer Therapy DOI
Wenpei Fan, Bryant C. Yung, Peng Huang

et al.

Chemical Reviews, Journal Year: 2017, Volume and Issue: 117(22), P. 13566 - 13638

Published: Oct. 19, 2017

The complexity, diversity, and heterogeneity of tumors seriously undermine the therapeutic potential treatment. Therefore, current trend in clinical research has gradually shifted from a focus on monotherapy to combination therapy for enhanced treatment efficacy. More importantly, cooperative enhancement interactions between several types contribute naissance multimodal synergistic therapy, which results remarkable superadditive (namely "1 + 1 > 2") effects, stronger than any single or their theoretical combination. In this review, state-of-the-art studies concerning recent advances nanotechnology-mediated will be systematically discussed, with an emphasis construction multifunctional nanomaterials realizing bimodal trimodal as well intensive exploration underlying mechanisms explaining significant improvements outcome. Furthermore, featured applications overcoming tumor multidrug resistance, hypoxia, metastasis also discussed detail, may provide new ways efficient regression even elimination drug resistant, hypoxic solid, distant metastatic tumors. Finally, some design tips outlook future development provided, highlighting key scientific issues technical challenges requiring remediation accelerate translation.

Language: Английский

Citations

1595

Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies DOI
Samir Mitragotri, Paul A. Burke, Róbert Langer

et al.

Nature Reviews Drug Discovery, Journal Year: 2014, Volume and Issue: 13(9), P. 655 - 672

Published: Aug. 8, 2014

Language: Английский

Citations

1464

The blood–brain barrier and blood–tumour barrier in brain tumours and metastases DOI
Costas D. Arvanitis, Gino B. Ferraro, Rakesh K. Jain

et al.

Nature reviews. Cancer, Journal Year: 2019, Volume and Issue: 20(1), P. 26 - 41

Published: Oct. 10, 2019

Language: Английский

Citations

1283